Skip to content
Hindi News, हिंदी समाचार, Samachar, Breaking News, Latest Khabar – Pratirodh

Hindi News, हिंदी समाचार, Samachar, Breaking News, Latest Khabar – Pratirodh

Primary Menu Hindi News, हिंदी समाचार, Samachar, Breaking News, Latest Khabar – Pratirodh

Hindi News, हिंदी समाचार, Samachar, Breaking News, Latest Khabar – Pratirodh

  • Home
  • Newswires
  • Politics & Society
  • The New Feudals
  • World View
  • Arts And Aesthetics
  • For The Record
  • About Us
  • Featured

India’s Covid-19 Tally Climbs To 7.65 Million

Oct 21, 2020 | Pratirodh Bureau

FILE PHOTO: Relatives wearing protective face masks lower the body of a woman, who died from the coronavirus disease, during her funeral at a graveyard in New Delhi on August 17, 2020

India has recorded 54,044 new coronavirus infections, taking its tally to 7.65 million, Health Ministry data showed on Wednesday.

The world’s second most populous nation also has the second highest caseload, after the United States, which has a total of 8.2 million cases.

India’s death toll from the virus stood at 115,914, with 717 deaths in the last 24 hours, the Ministry said.

Infections in India have been on the decline since a September peak, but experts have warned there could be a surge as the festival season approaches.

Meanwhile, AstraZeneca Plc’s COVID-19 vaccine trial in the United States is expected to resume as early as this week after the U.S. Food and Drug Administration completed its review of a serious illness in a study participant.

AstraZeneca’s large, late-stage U.S. trial has been on hold since Sept. 6, after a participant in the company’s UK trial fell ill with what was suspected to be a rare spinal inflammatory disorder called transverse myelitis.

AstraZeneca, which is developing the vaccine with Oxford University researchers, had been seen as a frontrunner in the race to produce a vaccine for COVID-19 until its trials were put on hold to investigate the illness. Early data from large-scale trials in the United States of vaccines from Pfizer Inc and Moderna Inc are expected some time next month.

Johnson & Johnson last week paused its Phase III COVID-19 vaccine trial to investigate an unexplained illness in a study participant. At the time of the announcement, the company did not know whether the volunteer had been given its vaccine or a placebo.

A J&J spokesman on Tuesday said the study remains on pause as the company continues its review of medical information before deciding to restart the trial. J&J noted last week that its “study pause” was voluntary. By contrast, AstraZeneca’s trial is on “regulatory hold,” which is imposed by health authorities.

Vaccines are seen as essential to helping end the pandemic that has battered economies around the world and claimed more than 1 million lives – over 220,000 of them in the United States.

 

Tags: AstraZeneca, coronavirus, COVID vaccine, COVID-19, FDA, Health Ministry, india, Oxford University, Pratirodh, U.S. Food and Drug Administration

Continue Reading

Previous ‘Vendetta’: Kashmir Newspaper’s Office Sealed By Officials
Next Pandemic Speeds Labour Shift From Humans To Robots

More Stories

  • Featured

Indian Economy Yet To Revive From Effects Of Pandemic: CPI (M)

1 hour ago Pratirodh Bureau
  • Featured

New Pipelines Will Fragment Assam’s Protected Forests: Environmentalists

2 hours ago Pratirodh Bureau
  • Featured

The Role Of Urban Foraging In Building Climate-Resilient Food Systems

15 hours ago Pratirodh Bureau

Recent Posts

  • Indian Economy Yet To Revive From Effects Of Pandemic: CPI (M)
  • New Pipelines Will Fragment Assam’s Protected Forests: Environmentalists
  • The Role Of Urban Foraging In Building Climate-Resilient Food Systems
  • Now, A ‘Private’ Sainik School Linked To RSS?
  • About 3,000 Tech Employees Being Fired A Day On Average In Jan
  • War Veteran Doctor, ‘Rasna’ Creator Are Among Padma Awardees
  • Black Days Ahead If Coal City Doesn’t Change
  • US Firm Alleges ‘Brazen’ Fraud By Adani, Who Calls It Malicious
  • Why Ukraine War Today Is So Different From A Year Ago
  • No Screening Of BBC Docu At JNU As Power, Internet Cut
  • Shielding The Hijol From Climate Impacts
  • Bilkis Bano’s Plea Against Convicts’ Remission Could Not Be Heard In SC
  • NDRF To Station Permanent Teams In Hills For Rescue Operations
  • Thousands Of Indian IT Professionals Jobless In The US
  • How Solar-Powered Refrigerators Slow Down Climate Change
  • Compensation For Crop Loss: Landless, Tenant Farmers Miss Out
  • Peru Closes Machu Picchu As Anti-Government Protests Grow
  • There Was No Need To Scrap Article 370: Dulat
  • RSS Ideology And Netaji’s Ideals Poles Apart: Anita Bose-Pfaff
  • UN Sorry For Photo Of Its Personnel In Front Of Taliban Flag

Search

Main Links

  • Home
  • Newswires
  • Politics & Society
  • The New Feudals
  • World View
  • Arts And Aesthetics
  • For The Record
  • About Us

Related Stroy

  • Featured

Indian Economy Yet To Revive From Effects Of Pandemic: CPI (M)

1 hour ago Pratirodh Bureau
  • Featured

New Pipelines Will Fragment Assam’s Protected Forests: Environmentalists

2 hours ago Pratirodh Bureau
  • Featured

The Role Of Urban Foraging In Building Climate-Resilient Food Systems

15 hours ago Pratirodh Bureau
  • Featured

Now, A ‘Private’ Sainik School Linked To RSS?

22 hours ago Shalini
  • Featured

About 3,000 Tech Employees Being Fired A Day On Average In Jan

1 day ago Pratirodh Bureau

Recent Posts

  • Indian Economy Yet To Revive From Effects Of Pandemic: CPI (M)
  • New Pipelines Will Fragment Assam’s Protected Forests: Environmentalists
  • The Role Of Urban Foraging In Building Climate-Resilient Food Systems
  • Now, A ‘Private’ Sainik School Linked To RSS?
  • About 3,000 Tech Employees Being Fired A Day On Average In Jan
Copyright © All rights reserved. | CoverNews by AF themes.